Carolinas Pain Institute
Winston-Salem, North Carolina, 27103, United States
NCT Number: NCT00263575
The purpose of this study is to evaluate the long-term safety and effectiveness of EN3267 in treating breakthrough pain episodes in opioid cancer patients who are using stable doses of opioid medication.
Looking for future studies?
Notify Me17 year and older
All sexes
Interventional
Phase 3
Winston-Salem, North Carolina, 27103, United States
This was a Phase 3 non-randomized, open-label, multicentre study designed to evaluate the long-term safety of EN3267 in the treatment of BTcP in opioid-tolerant cancer patients. The study was conducted in 2 parts:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
EN3267 will be available in 100, 200, 300, 400, 600 (two 300 ug tablets), and 800 ug (two 400 ug tablets) doses
Other names: Fentanyl
Time frame: screening, 2 week titration period and 12 monthly study visits
Kyowa Kirin Co., Ltd.
Industry
A Multiple-Dose, Non-Randomized, Open-Label, Multicenter Study to Evaluate the Long-Term Safety and Effectiveness of EN3267 in the Treatment of Breakthrough Pain in Cancer Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00125294
Breakthrough Pain, Cancer
View Trial DetailsNCT02437929
Breakthrough Pain, Cancer
Latina, Italy
View Trial DetailsNCT05869604
Behavior, Cancer
Durham, North Carolina, United States
View Trial DetailsNCT00646945
Cancer, Neoplasms
Vandœuvre-lès-Nancy, France
View Trial Details